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Abstract 
Juliana D’Onofrio 
ATTITUDES AND PREFERENCES ABOUT THE STEPPED-CARE MODEL OF 
DEPRESSION TREATMENT IN ONCOLOGY: A PILOT STUDY 
2016-2017 
Jim A. Haugh, Ph.D. 
Master of Arts in Clinical Mental Health Counseling 
 
 The current pilot study examines the feasibility of conducting a full-scale study 
that utilizes a survey-based cross-sectional methodological design. The purpose was to 
systematically explore the attitudes about the Stepped-Care (SC) Model of depression 
treatment, specific treatment preferences for depression, and client characteristics of a 
sample of women diagnosed with breast cancer. A total of 26 women were recruited from 
a breast cancer clinic located in the Northeastern United States. Preliminary results 
indicated that participants on average rated treatments within the SC Model as 
acceptable, tended to prefer step three (e.g. psychotherapy, medication, or a combined 
approach) or step two (e.g. self-help, or psychoeducation) of the SC Model, and tended to 
express strong to very strong preferences. Additionally, correlational analysis indicated 
moderate to strong significant relationships between the severity of depressive symptoms, 
quantified resilience, and emotional and cognitive perceptions of the illness. The current 
pilot study’s preliminary results are to be interpreted with caution and guide future 
directions in conducting a full-scale study with a larger and more representative sample. 
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Chapter 1 
Introduction 
In 2017, an estimated 252,710 women will be diagnosed with breast cancer (The 
American Cancer Society Medical and Editorial Content Team, 2017). Receiving a 
diagnosis, undergoing treatment, including breast-conserving surgery, mastectomy, 
chemotherapy, or radiation, and the uncertainty of treatment outcome place stress on the 
patient. It is expected that women with breast cancer experience distress during these 
times; however, a subsection of this population experience clinically significant 
depression, which might warrant and benefit from further psychological or behavioral 
treatment (Fann et al., 2008). Meta-analyses have estimated that 5-45% of women 
diagnosed with breast cancer experience a co-occurrence of clinical depression, with 
most studies indicating prevalence between 20-25% (Fann et al., 2008; Hegel et al., 
Pasquini & Biondi, 2006; Burgess et al., 2005).  
As a result to reported prevalence variability, researchers have spent time 
identifying when women with breast cancer are most susceptible to experiencing clinical 
depression. For example, studies have indicated that rates of depression are highest in 
younger women, within the first year following diagnosis, when patients are undergoing 
adjunctive treatment including chemotherapy and/or surgery, and when women 
experience a recurrence of their cancer diagnosis (Fann et al., 2008; Hegel et al., Pasquini 
& Biondi, 2006; Burgess et al., 2005). In addition, Passik et al. (1998) compared 
oncologists’ recognition of depression and patients’ self-reports of depressive symptoms. 
Results indicated that oncologists have a tendency to underestimate the severity of 
depressive symptomatology, with oncologists accurately recognizing only 13% of 
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patients reporting moderate to severe depressive symptoms (Passik et al., 1998). Thus, 
rates of women diagnosed with breast cancer who experience clinical depression are 
likely underrepresented. 
Statement of the Problem 
Despite variability with regards to prevalence of depressive symptoms, the 
negative consequences that cancer patients experience with a co-occurrence of depression 
are evident. Such negative consequences center on the progression and prognosis of the 
patient’s cancer. For example, the Biobehavioral Model of Cancer Stress and Disease 
Course describes the interplay that may occur between the psychological, behavioral, and 
biologic pathways from the stress of a cancer diagnosis (Andersen, Kiecolt-Glaser, & 
Glaser, 1994). More specifically, depression further inhibits the function of the 
hypothalamic-pituitary-adrenal (HPA) axis. Thus, the patient’s immune system is 
adversely impacted by both the diagnosis of cancer and depressive symptoms, which 
combined result in elevated mortality rates (Spiegel & Giese-Davis, 2003). Additionally, 
an oncology patient experiencing depressive symptoms is less likely to adhere to medical 
treatment, attend cancer-prescreening procedures, and follow doctor recommendations 
for a healthy living style, such as not smoking, maintaining proper nutrition, and 
exercising regularly (Pinquart & Duberstein, 2010).  Furthermore, quality of life is not 
only negatively affected by the diagnosis of cancer but by the symptoms present in 
depression, such as negative affectivity, anhedonia, fatigue, and lack of motivation 
(Spiegel & Giese-Davis, 2003).  
Moreover, Fann et al., (2008) conducted a meta-analysis to examine the impact of 
depression on breast cancer patients. Results indicated that depressive symptoms lead to a 
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number of additional negative consequences that are specific to women diagnosed with 
breast cancer. First, depression may amplify and act as a secondary cause to somatic pain 
making medical treatment more difficult. Second, depressive symptoms can further 
contribute to both cognitive and sexual dysfunctions that might develop as a result of the 
cancer diagnosis. Finally, depression might impact and exacerbate menopausal symptoms 
through the potential contraindication of estrogen replacement. Taken together, these 
consequences tend to overwhelm the overall coping abilities of the individual (Fann et 
al., 2008). 
Considering the variety of complications women with both breast cancer and 
depression face, it is important to assess and effectively treat depressive symptoms within 
this population. Current traditional procedures and modalities of psychological treatments 
do exist, including psychotherapy and antidepressant medications (Grassi et al., 2014; 
Van Schaik et al., 2004; Lawrenson, Tryer, Newson, & Farmer, 2000). However, while 
psychotherapy and antidepressants have been indicated to be effective in reducing 
depressive symptoms, there are a number of barriers when considering these treatments. 
For example, psychotherapeutic interventions are rarely accessible within hospitals and 
oncology centers. Therefore, once patients are identified as depressed, they typically must 
undergo a referral process to an external mental health agency, which may also take time, 
include high cost, and may be inconvenient with regards to further transportation (Grassi 
et al., 2014). Antidepressants, on the other hand, are more accessible within hospitals and 
oncology centers; however, medications come with a number of adverse side effects, 
potential drug-to-drug interactions, and simply might not be acceptable to the patient 
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resulting in lower or inconsistent adherence (Lawrenson, Tryer, Newson, & Farmer, 
2000).  
Significance of the Current Study 
As a result to these treatment barriers, studies have been conducted to examine 
other potential factors that may improve treatment dissemination for depression in 
oncology. In addition to being a key component in the Evidence-Based Behavioral 
Practice (EBBP) Model, previous literature strongly indicates that incorporating the 
client’s characteristics throughout treatment leads to a number of beneficial results (APA 
Task Force, 2006). For example, previous research has indicated that attending to the 
client’s treatment preferences increase adherence (Kwan, Dimidjian, & Rizvi, 2010), lead 
to better therapeutic relationships (Iacoviello et al., 2007), lower rates of attrition, 
increase motivation in treatment (Swift & Greenberg, 2015), and improve overall clinical 
outcomes (Lin et al., 2005; Swift & Callahan, 2009; Lindhiem, Bennett, Trentacosta, and 
McLear, 2014). Furthermore, rates of treatment satisfaction have been supported to 
increase when clinicians make an effort to collaborate with patients when formulating 
treatment (Lindhiem, Bennett, Trentacosta, & McLear, 2014).  
In addition to attending to treatment preferences, other client characteristics have 
been examined in acutely and chronically ill individuals. Such characteristics have 
included quantified individual resilience and the individual’s emotional and cognitive 
perceptions of the illness. More specifically, previous literature has associated these 
constructs with depressive severity and psychological functioning following a diagnosis. 
For example, in a study conducted on patients diagnosed with prostate cancer, level of 
resilience was significantly and negatively associated with the severity of depressive 
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symptoms (Sharpley, Bitiska, Wootten, & Christie, 2014). Furthermore, resilience is also 
utilized as a marker for progress in treatment and has been indicated to be significantly 
and positively associated with successful treatment outcomes (Min et al., 2012). With 
regards to the individual’s emotional and cognitive perceptions of their illness, meta-
analytic review has indicated that individuals who endorse perceptions that their illness is 
more chronic, uncontrolled, and symptomatic are more likely to experience psychological 
distress. On the other hand, individuals who endorse perceptions that their illness is more 
curable and controlled are more likely to be psychologically and socially adaptable 
(Hagger & Orbell, 2003). 
Given the clinical implications of attending to client characteristics, models of 
care have been developed that recommend assessing for these different factors prior to 
formulating a treatment plan. One model that considers client characteristics as a major 
component of treatment formulation is the Stepped-Care (SC) Model (Broten, Naugle, 
Kalata, & Gaynor, 2011). The SC Model recommends different treatments for depression 
depending upon treatment preferences, collaboration with the client, and severity of 
presenting symptoms (Li et al., 2008). Steps and treatment options within this model 
range from low-intensity interventions to high-intensity interventions. More specifically, 
the first step of the SC Model of treatment recommends watchful waiting, attributing 
improvement of depressive symptoms only to time. The second step of this model 
recommends the use of psychoeducation, bibliotherapy (e.g. self-help), or computer-
based programs aimed at treating depression (e.g. self-help via the Internet based on 
cognitive or behavioral principles). The third step of this model recommends attending 
support groups, individual psychotherapy, or taking antidepressant medications. Finally, 
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the fourth and most intensive step of this model recommends intensive outpatient/partial 
day, or inpatient care (Broten, Naugle, Kalata, & Gaynor, 2011).    
 Since the development of the SC Model, psychological researchers have 
examined the efficacy of implementing this model within oncology and primary care 
settings. For example, an expert panel in an oncology center in Ontario created a quality 
initiative for evidence-based care for the management of depression in patients with 
cancer. This initiative strongly incorporated the use of the SC Model in guidelines to 
treating depressive symptoms in patients (Li et al., 2015). Additionally, the SC Model has 
been empirically supported in the Netherlands, Canada, and the United Kingdom (van 
Straten, Hill, Richards, & Cuijpers, 2015; Li et al., 2015; Firth, Barkham, & Kellett, 
2015; van’t Veer-Tazelaar et al., 2010). Results have indicated of a number of positive 
implications for the use of SC Model compared to treatment as usual or standard care 
practices. First, meta-analytic review indicates small to moderate effect sizes in favor of 
the SC Model when compared to treatment as usual (d = .20-.45; Firth & Barkham, & 
Kellett, 2015). Second, cost effectiveness of the SC Model was consistently seen as an 
augmented benefit across meta-analyses. Finally, attending to the treatment preferences 
of the patient and engaging in collaborative treatment formulation moderated the overall 
efficacy of the psychological intervention (van Straten, Hill, Richards, & Cuijpers, 2015; 
Firth, Barkham, & Kellett, 2015; van’t Veer-Tazelaar et al., 2010).    
Despite the support for the use of the SC Model internationally, limitations exist 
within this literature base. First, no study has yet to be conducted that has examined the 
efficacy of the SC Model within the United States, starting with how individuals might 
view this model of care. The importance of disseminating empirically supported and cost 
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effective treatments in oncology settings, emphasizes the rationale for exploring how 
patients might view the SC Model of treatment in comparison to standard care practices. 
The SC Model suggests that there are less-intensive treatment options available, such as 
psychoeducation and self-help. Such low-intensity interventions that are cost-effective 
have also been supported to be effective as stand-alone treatments for reducing 
depressive symptoms (Broten, Naugle, Kalata, & Gaynor, 2011). For example, 
psychoeducation alone is supported to be effective in reducing subclinical and mildly 
clinical levels of depressive symptomatology (Cuijpers, 1998). In addition, guided self-
help has been supported to be comparable to face-to-face individual psychotherapy in 
treating depression (Cuijpers, Donker, van Straten, & Andersson, 2010).  
A second limitation is that there has been little research conducted on what 
psychological treatments oncology patients might prefer if seeking mental health services 
for depressive symptoms. With regards to women with breast cancer, only two studies 
have explored treatment preferences for depression (Wu, Brothers, Ferrar, & Anderson, 
2015; Reece et al., 2013). While these results indicate that participants tended to prefer 
individual psychotherapy, studies lacked in exploring possible preferences for treatments 
other than traditional interventions, including self-help and psychoeducation, and one of 
the above study did not assess for depressive symptoms (Wu, Brothers, Ferrar, & 
Anderson, 2015). Given what is known about the impact of depression on cancer and the 
benefits of attending to treatment preferences, preferences should be further explored 
within oncology populations. A patient diagnosed with cancer who is also experiencing 
depressive symptoms is often coping with multiple obligations, including frequent doctor 
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visits, pain, fatigue, and medical expenses. Thus, these patients might prefer a lower 
intensity treatment option.  
A final limitation is that no study has explored the possible relationships between 
the severity of depressive symptoms, quantified resilience, and individual perception of 
the illness in a sample of women with breast cancer. These characteristics warrant further 
exploration for a number of reasons. Given the associations between illness perception 
and psychological functioning, and the impact of resilience on treatment process and 
outcome, it might prove beneficial to measure these constructs prior to treating women 
with breast cancer for depressive symptoms.  
Purpose of the Current Study 
The aforementioned limitations warrant for further examination of psychological 
treatment for depression in oncology. Given the limited existing previous research, a pilot 
study was conducted to assess the feasibility of conducting a full scale study with a more 
representative sample size. Thus, a cross-sectional study design was formulated that 
consisted of five exploratory goals. The first goal was to assess the acceptability of the 
SC Model through providing participants with a description of the model as well as what 
each step of the model recommends. The second goal was to assess what step and what 
treatment within that step participants would prefer if seeking mental health services for 
depressive symptoms. Being that acceptability (i.e. the ability to be tolerated) and 
preference (i.e. a greater liking over other alternatives or options) are separate terms, 
indicating what one perceives to be most acceptable does not automatically indicate a 
corresponding preference. Therefore, for the purpose of the current pilot study, 
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participants will be assessed for how acceptable they perceive the SC Model to be and 
what treatment is preferred the most.  
Previous literature has indicated that the benefits that might result from attending 
to treatment preferences are moderated by how strongly the individual prefers that 
treatment (Swift & Greenberg, 2015). As a result, the third goal of the current pilot study 
was to assess the strength of participants’ preferences for the step of the SC Model and 
treatment within that step. The fourth goal was to assess for depressive symptoms and to 
explore differences between the severity of symptoms and the treatments participants 
prefer. The guidelines and the structure of the SC Model state that the severity of 
presenting depressive symptoms should be highly considered when deciding which step 
is optimal for a given patient. For example, a step one (e.g. watchful waiting) approach 
would not be suitable for an individual endorsing a more severe level of depression 
compared to an individual endorsing a subclinical or minor level of depression. Thus, the 
current study seeks to examine whether participants tend to prefer treatments in which the 
intensity corresponds to severity of depressive symptoms. The fifth and final goal was to 
explore the constructs of resilience and illness perception in relation to depressive 
symptom severity and treatment preferences.  
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Chapter 2 
Method 
Participants 
 A total of 26 participants of the current study were recruited through a breast 
cancer clinic within an oncology center located in the Northeastern United States. 
Potential participants were identified with the help of schedulers employed in the breast 
cancer clinic and researchers approached patients within the consultation room prior to or 
following doctor appointments with the oncologist. The incentive for participation 
included being given the choice to enter into a raffle for $100 that would be conducted 
following all participant recruitment. In order to be eligible for the current study, 
participants were required to identify as female, have a diagnosis of breast cancer, be at 
least 18-years-old, and be able to read and understand a 6th grade reading level. 
Participants’ ages ranged from 32 to 65 (M=49.91). Participants in the sample 
predominantly identified as Caucasian (84%), followed by African American (8%), and 
other (8%). Seventy-seven percent of participants identified as Non-Hispanic/Latino. 
Measures 
 Center for Epidemiologic Studies for Depression, Short Form (CES-D-10; 
Radloff, 1977). The CES-D-10 is a 10-item self-report measure that assesses for the 
presence of depressive symptoms. Questions are asked on a 4-point Likert scale, ranging 
from (0) less than 1 day – Rarely or none of the time, to (3) 5-7 days – All of the time. 
Total scores on the CES-D-10 range from 0-30 and a total score of at least 10 indicates 
the presence of depressive symptoms. The CES-D-10 has been indicated to have good 
internal consistency and test-retest reliability (Cronbach’s α = 0.86 and r = 0.85, 
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respectively; Miller, Anton, & Townson, 2008). The CES-D-10 has also been indicated to 
have high convergent and divergent validity (.91 and .89, respectively; Miller, Anton, & 
Townson, 2008). 
 The Connor-Davidson Resilience Scale, 10-item (CD-RISC 10; Connor, & 
Davidson, 2003). The CD-RISC 10 is a 10-item self-report scale that quantifies an 
individual’s resilience level in order to assess potential for modifiability. Questions are 
asked on a 5-point Likert scale, ranging from (0) Not True At All, to (4) True Nearly All 
the Time. The CD-RISC is utilized for a number of purposes including assessing the 
degree of resilience an individual has, measuring resilience as a predictor variable to 
treatment outcome, and as a marker for change throughout treatment and in changing 
biological modifications. Total scores range from 0-40, with higher total scores reflecting 
a greater level of resilience. Total scores are typically compared to the means of the 
specific population being studied. A recent study indicated that the mean total score for 
the CD-RISC 10 in a sample of breast cancer patients was 27.6 (SD=5.9; Markovitz, 
Schrooten, Arntz, & Peters, 2015). The CD-RISC 10 has been indicated to have good 
internal consistency and test-retest reliability (Cronbach’s α = 0.89 and r = 0.88, 
respectively; Notario-Pacheco et al., 2014).   
Brief Illness Perception Questionnaire (Brief IPQ; Broadbent, Petrie, Main, 
& Weinman, 2006). The Brief IPQ is a 9-item self-report scale that assesses the 
individual’s cognitive and emotional perceptions their illness. The Brief IPQ includes 
eight items that are asked on a 10-point Likert scale, with ranges specific to the question. 
An example of a question and corresponding scale is “How much does your illness affect 
your life?” with a 10-point Likert scale ranging from (0) No Affect at All, to (10) Severely 
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Affects My Life. The ninth item on the Brief IPQ provides qualitative data and is an open-
ended question that asks the individual to rank-order the three most important factors that 
are believed to have caused his or her illness. For purpose of the current pilot study, this 
item was excluded as a means to lessen psychological risk to the participant. Total scores 
of the Brief IPQ range from 0-80 and indicate the degree to how threatening the illness is 
perceived, with higher scores indicating a more threatening view of the illness. The Brief 
IPQ individual items have been indicated to have good test-retest reliability at three and 
six weeks (r = .48-.70 and r = .42-.75, respectively; Broadbent, Petrie, Main, & 
Weinman, 2006) and high internal consistency (Cronbach’s α = 0.85; Karatas, Ozen, & 
Kutluturkan, 2017).  
 Treatment Preference Inventory (TPI). The TPI was created by the researchers 
for the purpose of the current study. The TPI is at least 11 items and at most 27 items 
depending on individual answers and skip logic present throughout the inventory. The 
inventory is a self-report questionnaire that assesses for the acceptability of the SC Model 
and preferences for specific treatments within the SC Model. Items on the TPI utilize 
dichotomous and 5-point Likert scales with ranges specific to the question being asked. 
An example of a question assessing for acceptability of a specific treatment is, “Do you 
find watchful waiting to be an acceptable form of treatment?” with a 5-point Likert scale 
ranging from (1) Not Acceptable, to (5) Very Acceptable. The inventory provides a 
description of the SC model and descriptions of each step and treatment of the model, 
including active and inactive interventions. The inventory begins with step one, including 
watchful waiting, and proceeds with step two, including psychoeducation or self-help, 
step three, including psychotherapy, medication, or a combined psychotherapy and 
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medication approach, and finally step four, including an intensive outpatient/partial day 
program or inpatient program. Descriptions consist of what one could expect if receiving 
each of the aforementioned interventions (e.g. time, contact with a mental health 
professional, and rationale for specific treatment). Reading level for the inventory was 
assessed using the Simple Measure of Gobbledygook index, with results indicating an 8.4 
reading level (Doak, Doak, & Root, 1996; McLaughlin, 1969). See Appendix for the full 
Treatment Preference Inventory. 
  “Imagine-Self” Vignette. The current study sampled patients who may or may 
not have been experiencing or seeking help for depressive symptoms. Thus, participants 
were also given an “Imagine-Self” Vignette. It has been indicated that when participants 
are asked to imagine a specific perspective that is different from their own, the individual 
will experience self-thoughts comparative to that target perspective (Davis et al., 2004).  
 Demographic, Medical, and Psychological History Questionnaire.  
Demographics included gender, age, ethnicity, and race. Medical information asked 
included type of cancer diagnosis, stage of cancer diagnosis, and how recently participant 
was diagnosed with cancer. Psychological history included past experience with seeking 
help for mental health symptoms, what treatment may have been received (e.g. talking 
treatment, drug treatment, both, or other), past experience with depressive symptoms, and 
how recent this experience with depressive symptoms was. 
Procedure 
Preceding data collection, measures were entered into the online survey-based 
website of Qualtrics. If the patient agreed to participate, the researchers verbally 
explained the consent form that outlined the individual’s rights, the purpose of the study, 
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study incentive, potential risks and benefits of the study, and expectations of the 
participant. If the individual agreed to consent, signature was obtained and the individual 
was given an identification number. The participant was then given the option to either 
complete the measures within the consultation room or at a later time of the individual’s 
leisure. Participants that wished to complete the questionnaires at a later time were given 
their identification number and the link to the measures on Qualtrics. Participants that 
wished to complete measures within the consultation room were provided a tablet/iPad 
with Qualtrics and asked to complete the study at that time.  
Participants first entered their identification number. Second, participants entered 
information on demographics, medical diagnosis, and psychological history. Third, 
participants completed the CES-D-10, the Brief IPQ, the CD-RISC 10, and the TPI. Last, 
participants were debriefed. Full participation lasted approximately 20 minutes. All 
participant information remained protected through the Health Insurance Portability and 
Accountability Act (HIPAA) for Protected Health Information (PHI) and questionnaire 
answers were kept confidential. Procedures of this study were approved by the hospital’s 
ethical Institutional Review Board (eIRB). 
Statistical Analyses 
 Results within this study utilized descriptive and inferential data, including 
frequencies, correlations, and nonparametric statistical analyses. Frequencies were 
utilized to examine overall acceptability ratings, preferences for the treatments within the 
SC model, strength of preferences, and differences between depressive symptom severity 
and final choice of treatment. A nonparametric chi-square goodness of fit analysis was 
utilized to examine significant differences in observed and expected frequencies of what 
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step participants indicated they would most prefer if seeking help for depressive 
symptoms. Last, correlational analyses were utilized to examine possible relationships 
between depressive symptom severity, resilience level, and illness perception.  
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Chapter 3 
Results 
Medical Information and Psychological History 
 Participants in the sample were predominantly diagnosed with either Stage 2 
(n=8; 31%) or Stage 4 (n=8; 31%) breast cancer, followed by Stage 1 (n=5; 19%), 
Precancerous (n=3; 11%), and Stage 3 (n=1; 4%). One participant was uncertain of what 
Stage their diagnosis was (4%). Half of participants indicated that they have had their 
diagnosis for more than one year (n=13). Sixty-two percent of participants indicated that 
they are currently or have in the past received mental health services (n=16), with most 
indicating services to be a combined medication and psychotherapeutic approach (n=13; 
50%), followed by psychotherapy (n=4; 25%), medication (n=3; 19%), and other (n=1; 
6%). Seventy-seven percent of participants indicated that they have experienced 
depressive symptoms (n=20), with most indicating that the experience has been within 
the past 3 months (n=9; 45%). 
Acceptability of SC Model 
 SC Model and treatment acceptability was assessed through normative data, 
specifically mean ratings, utilizing 5-point Likert scales ranging from (1) Not Acceptable 
to (5) Very Acceptable. Results indicated that step three (e.g. psychotherapy, medication, 
or a combination) of the SC Model was rated to be on average the most acceptable step, 
with psychotherapy and medication rated as equally acceptable (M=4.31, SD=1.09 and 
M=4.31, SD=1.16; respectively), followed by a combined psychotherapeutic and 
medication approach (M=4.23, SD=1.07). Step two (e.g. self-help, or psychoeducation) 
of the SC Model was rated to be on average the second most acceptable step, with 
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psychoeducation rated as slightly more acceptable than self-help (M=3.50, SD=1.45 and 
M=3.31, SD=1.32; respectively). Step four (e.g. intensive outpatient, or inpatient) of the 
SC Model was rated to be on average the third most acceptable step, with intensive 
outpatient programs rated as slightly more acceptable than inpatient programs (M=3.00, 
SD=1.60 and M=2.54, SD=1.68; respectively). Finally, step one (e.g. watchful waiting) 
of the SC Model was rated to be on average the fourth most acceptable step (M=2.23; 
SD=1.21). See Figure 1 for full depiction of participants’ mean acceptability ratings for 
each treatment within the SC Model. 
 
 
 
 
Firgure 1. Mean Acceptability Ratings for Each Treatment in SC Model.  
WW = Watchful Waiting, PsyE = Psychoeducation, SH = Self-Help, M = Medication, P 
= Psychotherapy, CMP = Combined Medication/Psychotherapy, IOP = Intensive 
Outpatient, and IP = Inpatient. 
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Treatment Preferences  
 Descriptive statistics indicated that when asked what step participants would 
prefer to start with if they were to seek help for depressive symptoms, step three was 
chosen most frequently (n=14, 53.8%), followed by step two (n=8; 30.8%), and step one 
(n=4; 15.4%). No participant indicated a preference for step four. Chi-square goodness of 
fit analysis indicated at least one step of the SC Model was chosen significantly different 
than what would be expected on a normal distribution (χ2 (3, 26) = 16.46, p < .001). See 
Table 1 for full depiction of chi-square goodness-of-fit analysis of observed and expected 
frequencies for participants’ preferred step of the SC Model. Additionally, participants 
tended to express strong (n=10; 38.5%) to very strong (n=10; 38.5%) preferences for the 
step they indicated to prefer (M=4.12, SD=.86). 
 
 
Table 1.  
Frequencies for Step of SC Model Participants Preferred 
 Step One Step Two Step Three Step Four 
Observed Freq. 4 8 14 0 
Expected Freq. 
(prop.) 
6.5 (.25) 6.5 (.25) 6.5 (.25) 6.5 (.25) 
Note. χ2 = 16.46**, df = 3. Numbers in parentheses, (), are expected proportions.  
Freq. = frequencies and prop. = proportion. 
** p < .01.  
 
 
 
With regards to examining treatment preferences further, within step three, 
descriptive statistics indicated that a combined psychotherapeutic and medication 
approach was chosen most frequently (n=8; 57.1%), followed by medication alone (n=4; 
28.6%), and psychotherapy alone (n=2; 14.3%). When asked what type of psychotherapy 
would be preferred, most participants indicated a preference for cognitive therapy (n=5; 
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50%), followed by mindfulness (n=2; 20%), and behavioral activation (n=2; 20%), and 
finally interpersonal therapy (n=1; 10%). Participants predominantly indicated a 
preference for individual (n=8; 80%) versus group (n=2; 20%) psychotherapy. Within 
step two, descriptive statistics indicated that self-help was chosen equally as frequently as 
psychoeducation (n=4; 50%). When asked what type of self-help intervention would be 
preferred, more participants indicated a preference for mobile applications (n=2; 50%), 
followed equally by books and internet-based programs (n=1; 25%). Additionally, 
participants predominantly indicated a preference for guided (n=3; 75%) versus unguided 
(n=1; 25%) self-help.  
Depressive Symptoms, Resilience, and Illness Perception 
 Results indicated differences across mean total scores for the CES-D-10 and the 
step of the SC Model that participants indicated to prefer if they were to seek help for 
depressive symptoms. As participants preferred a more intensive step of the SC Model, 
participants also endorsed a higher level of depressive symptoms on the CES-D-10. More 
specifically, among participants that indicated a preference to start with step one, the total 
mean score for the CES-D-10 was indicated to be the lowest (M=11.25; SD=4.19), while 
the total score for the CES-D-10 steadily increased among participants that indicated a 
preference to start with step two (M=12, SD=9.02) and step three (M=15.71, SD=6.79). 
See Figure 2 for graph depiction of differences across the mean total CES-D-10 scores by 
preferred step for step one, step two, and step three.  
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Figure 2. Mean Total CES-D-10 Scores by Preferred Step.  
 
 
 
 
Correlational analyses indicated significant relationships between resilience, 
illness perception, and depressive severity. With regards to the quantified level of 
resilience of participants, total scores on the CD-RISC 10 were indicated to be strongly 
significant and negatively correlated with both total scores on the CES-D-10 (r(25) = -
.542, p < .01) and the Brief IPQ (r(25) = -.519, p < .01). With regards to the cognitive 
and emotional perceptions of the individual’s illness, total scores on the Brief IPQ were 
indicated to be moderately significant and positively correlated with total scores on the 
CES-D-10 (r(25) = .395, p < .05). See Table 2 for full depiction of correlational analysis 
for depressive symptoms, resilience, and illness perception. 
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Table 2. 
Correlations for Depressive Symptoms, Resilience, and Illness Perception 
 CES-D-10 CD-RISC 10 Brief IPQ 
CES-D-10 --   
CD-RISC 10 -.542** --  
Brief IPQ .395* -.519** -- 
Note. CES-D-10 = Center for Epidemiologic Studies for Depression Scale, Short Form, 
CD-RISC 10 = Connor-Davidson Resilience Scale, 10-item, and Brief IPQ = Brief Illness 
Perception Questionnaire.  
*p < .05. 
**p < .01. 
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Chapter 4 
Discussion 
 The purpose of the current pilot study was to assess the feasibility of the current 
study design in conducting future data collection. Considering the procedure, time of 
participation, and measures utilized within the current pilot study, the overall design was 
supported to be feasible. In addition, the current pilot study led to a number of 
preliminary results that will contribute to and guide future directions. The current pilot 
study sought to systematically explore how women with breast cancer view the SC 
Model for treating depressive symptoms and what treatments would be most preferred for 
treating depression. Preliminary results indicated that participants on average rated the 
steps and treatments within the SC Model to be moderately to strongly acceptable. With 
acceptability ratings ranging from 2.23-4.31 on a 5-point Likert scale, step three was on 
average rated as the most acceptable step, followed by step two, step four, and step one as 
least acceptable. Taken together, results suggest that the SC Model might be accepted in 
an oncology setting. 
 With regards to what step participants indicated to prefer, chi-square goodness-of-
fit analysis indicated significant differences from what would be expected on a normal 
distribution. Step three was indicated to be preferred most frequently, followed by step 
two, and last, step one. No participant indicated a preference for step four. Additionally, 
participants also tended to express strong to very strong preferences for what they 
indicated to prefer. Bearing in mind these preliminary results, there are a variety of cost-
effective self-help materials that have been developed by psychological researchers. 
While not all self-help materials that have been created are empirically supported, there 
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does exist empirical evidence for specific books, mobile applications, and Internet-based 
programs. Given that some participants did indicate strong preferences for non-traditional 
treatments, including psychoeducation and self-help, preliminary results further suggest 
the importance of exploring the SC Model in oncology. 
 Finally, the current pilot study also sought to systematically explore whether there 
was an association between the severity of depressive symptoms and individual patient 
characteristics, including quantified resilience and illness perceptions. Preliminary results 
indicated that all three constructs were strongly correlated with each other. More 
specifically, participants that endorsed a higher severity of depressive symptoms were 
more likely to have a lower quantified resilience and a more threatening view of their 
illness. In addition, participants who endorsed a lower quantified resilience were more 
likely to have a more threatening view of their illness. Considering these associations 
between depression, resilience, and illness perception, preliminary results further suggest 
that assessing for these characteristics might be important prior to and throughout 
treatment.  
Limitations and Future Directions 
 Given that the results reported are of a pilot, they should be interpreted with 
caution. Taking into account the current pilot study and the preliminary results, there will 
be a number of future directions that will be followed. First, future data collection will 
include a larger sample that will aim to be more demographically diverse and thus, more 
generalizable to the greater population. Second, in order to increase the validity of the 
implications and as data collection is ongoing, future analyses will include additional 
inferential and nonparametric statistical tests. Third, the current pilot sample consisted of 
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some non-treatment seeking individuals. The authors presented participants with an 
“Imagine Self” vignette to control for this extraneous variable. However, it is still 
possible that individuals who are seeking treatment may respond differently when asked 
to indicate specific treatment preferences compared to individuals who are not seeking 
treatment. Future analysis will include a closer examination of potential differences 
between participants who indicate that they are actively seeking psychological treatment 
and those who indicate that they are not. Finally, while women diagnosed with breast 
cancer was the target population, it is possible that there might be gender differences with 
both acceptability of the SC Model and specific treatment preferences. As a result, future 
data collection will include recruiting men diagnosed with prostate cancer to examine 
potential variability. 
Conclusion 
 The purpose of the current pilot study was to assess the feasibility of conducting a 
larger-scale study utilizing the current study design. Given the impact of depression on 
the progression and prognosis of women diagnosed with breast cancer, it becomes 
important to effectively treat depressive symptoms in oncology. Further, the current 
barriers to treating depression in this population warrant examining models of care that 
might improve the dissemination of psychological treatments to patients with cancer. 
Results of the current pilot study gave preliminary evidence on how patients might view 
the SC Model, what psychological treatment for depression might be preferable for a 
woman diagnosed with breast cancer, and how specific individual characteristics are 
related to each other. Finally, the preliminary results of the current pilot study will guide 
future data collection and statistical analyses. 
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Appendix 
Treatment Preference Inventory (TPI) 
  
The purpose of the Stepped-Care Model of treatment is to increase the intensity of 
treatment in four "steps." This model aims to begin with the lowest and least intensive 
form of treatment that is available for treating depressive symptoms. As steps increase, so 
does the intensity of treatment. Treatments range from no treatment at all (e.g. the least 
intensive) to inpatient hospitalization (e.g. the most intensive). Matching patients with the 
appropriate treatment depends on how much symptoms may be impacting one's life and 
which treatment one prefers to start with.  
 
Following this description are the treatments offered within each step of the Stepped-Care 
Model. Each description outlines what one could expect if given the treatment. Following 
each description are two questions on how acceptable you perceive the treatment to be. 
Please read each description and indicate the number that best corresponds to your 
personal views.  
 
STEP ONE: Also known as no treatment.  
 
Watchful Waiting: This option is also known as no treatment. While watchful waiting is 
not an active treatment, this option attributes improvement of symptoms to time.  
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1. Do you find watchful waiting to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
  
STEP TWO: Consists of options that can be achieved on one's own or with minimal 
contact with a mental health professional.  
 
Psychoeducation: This treatment includes learning information about depression as a 
disorder. Topics might include signs, symptoms, what one can expect when experiencing 
a depressive episode, and different ways one might be able to cope with depressive 
symptoms.  
 
2. Do you find psychoeducation to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Self-Help: Self-Help is defined as a self-directed activity aimed at improving one’s life. 
Specific goals of self-help might include learning problem-solving skills, gaining insight 
and awareness, managing difficulties you may be experiencing, improving relationships, 
and/or reaching your goals.  
 
3. Do you find self-help to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Skip Logic: If Not Acceptable Is Selected, Then Skip To STEP THREE: Consists of 
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weekly or mon...  
 
Format Self-Help: Self-Help can be guided or unguided. Guided consists of having a 
mental health professional provide weekly instructions and feedback about one's 
progress, while answering any possible questions. Unguided does not include any 
assistance from a mental health professional and can be completed fully on one's own.  
 
4. If you were to use self-help materials, would you prefer guided or unguided?  
o Guided 
o Unguided  
 
5. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
 
Delivery of Self-Help: There are a number of different delivery methods for self-help. 
For example, individuals can find resources through books, mobile applications, and 
Internet-based programs.  
 
6. If you were to use self-help materials, what delivery method would you prefer? 
o Books 
o Mobile Applications 
o Internet-Based Programs  
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7. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
 
STEP THREE: Consists of weekly or monthly contact with a mental health professional.  
 
Medication: Treatment consists of meeting with a prescriber at least once a month. 
Antidepressant medications work to balance some of the natural chemicals in our brains. 
These chemicals are called neurotransmitters, which affect mood and emotional 
responses.  
 
8. Do you find medication to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Psychotherapy: Treatment consists of engaging in weekly therapy sessions in order to 
develop skills to cope with and manage psychological distress.  
 
9. Do you find psychotherapy to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Combined Psychotherapy and Medication: Treatment consists of combining the two 
treatments listed above.  
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10. Do you find the combination of psychotherapy and medication to be an acceptable 
for of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Skip Logic: Answer If “Do you find psychotherapy to be an acceptable form of 
treatment?” Not Acceptable Is Not Selected Or “Do you find the combination of 
psychotherapy and medication to be an acceptable for of treatment?” Not Acceptable Is 
Not Selected  
 
Format of Psychotherapy: Psychotherapy can be delivered individually or through a 
group setting. Individual psychotherapy consists of a therapeutic relationship between a 
mental health professional and a client. Group psychotherapy typically consists of 6-10 
members. Group psychotherapy allows members to develop and follow treatment plans 
while also engaging in a social dynamic to learn different interpersonal skills.  
 
11. If you were to seek out psychotherapeutic services, would you prefer it to be 
individual or group? 
o Individual 
o Group  
 
12. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
 
34 
 
Skip Logic: Answer If “Do you find psychotherapy to be an acceptable form of 
treatment”? Not Acceptable Is Not Selected Or “Do you find the combination of 
psychotherapy and medication to be an acceptable for of treatment?” Not Acceptable Is 
Not Selected  
 
Different psychotherapies utilize a variety of theories and techniques. Below is a list of 
brief descriptions for different types of empirically supported psychotherapies for one 
who might be experiencing depression. For the following questions, please indicate the 
choice and number that best corresponds to your views.  
 
Cognitive Therapy (CT) for depression is based on the belief that depression is caused by 
negative thinking and distorted beliefs. Patients are taught to monitor and record their 
negative thoughts. This way they can identify the relationship between their thoughts, 
feelings, physical symptoms and behaviors.  
 
Behavioral Activation (BA) Therapy is based on the belief that when people get 
depressed, they withdraw from their environment, engage in escape behaviors, and stop 
following their routines. Over time, this avoidance worsens mood. The goal is to help 
patients create opportunities to find pleasure in activities they once enjoyed.  
 
Interpersonal Therapy (IPT) stresses the understanding and treating of depression by 
addressing interpersonal issues. IPT puts emphasis on the way symptoms are related to a 
person's relationships. This includes both family and peers.  
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Problem-Solving Therapy (PST) is based on the idea that depression can often be 
understood as the negative consequences of ineffective coping and problem solving. 
When one can’t cope with a situation or solve a problem, it stresses them out and worsens 
their depression. PST is aimed at helping the patient to improve their ability to cope with 
stressful life experiences and better solve their problems.  
 
Mindfulness is based on the concept that when one is depressed, they repeatedly think 
about everything that they believe to be wrong in their life. Mindfulness aims to help the 
patient by having them purposely focus on what is occurring in the present moment, 
without judgment in order prevent negative assumptions.  
 
13. Out of the above stated psychotherapies, which would you most prefer to receive 
if you were seeking psychotherapeutic services? 
o Cognitive Therapy (CT) 
o Behavioral Activation (BA)  
o Interpersonal Therapy (IPT) 
o Problem Solving (PST) 
o Mindfulness  
 
14. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
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Skip Logic: Answer If “Do you find psychotherapy to be an acceptable form of 
treatment?” Not Acceptable Is Not Selected Or “Do you find the combination of 
psychotherapy and medication to be an acceptable for of treatment?” Not Acceptable Is 
Not Selected  
 
15. Who of the following would you most prefer to receive psychotherapy from? 
o General Practitioner 
o Oncology Nurse 
o Mental Health Professional (e.g. counselor, therapist, psychologist)  
 
16. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
 
Skip Logic: Answer: If “Do you find medication to be an acceptable form of treatment?” 
Not Acceptable Is Not Selected Or “Do you find the combination of psychotherapy and 
medication to be an acceptable for of treatment?” Not Acceptable Is Not Selected  
 
17. Who of the following would you most prefer to receive medication from? 
o Psychiatrist 
o General Practitioner 
o Advanced Practiced Nurse  
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18. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong  
 
STEP FOUR: Consists of ample contact with a mental health professional.  
Intensive Outpatient or Partial Day Program: This treatment method includes actively 
attending a day program 3-5 times a week that can last anywhere from 3-6 hours each 
day. During this time, the member participates in group activities and group sessions that 
focus on various topics that surround depression as a mental illness.  
 
19. Do you find intensive outpatient and/or partial day programs to be an acceptable 
form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Inpatient Program: This treatment method includes hospitalization for 24 hours a day. 
During this time, mental health professionals will work to get you stabilized within a 72-
hour period in order to refer you to a lower level of care.  
 
20. Do you find inpatient programs to be an acceptable form of treatment? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
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Imagine that you have been experiencing symptoms of depression (i.e. depressed mood, 
loss of pleasure/interest in activities, feelings of guilt/worthlessness, difficulty 
concentrating, changes in weight/appetite while not dieting) and that you have decided to 
seek help for these depressive symptoms. For the following questions, please indicate 
which step you would prefer to start with given the level of depressive symptoms you 
might be experiencing or imagine to be experiencing.  
 
21. At which step of the Stepped-Care Model would you prefer to start? 
o Step One (e.g. Watchful Waiting) 
o Step Two (e.g. Psychoeducation and/or Self-Help) 
o Step Three (e.g. Psychotherapy and/or Medication)  
o Step Four (e.g. Intensive Outpatient, Partial Day Program, Inpatient Program)  
 
22. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong  
 
23. If you were starting treatment, what treatment within step two of the Stepped-
Care model would you prefer? 
o Psychoeducation 
o Self-Help (e.g. books, mobile applications, or Internet sites)  
 
24. How Strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
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25. If you were starting treatment, what treatment within step three of the Stepped-
Care model would you prefer? 
o Psychotherapy 
o Medication 
o Combined Psychotherapy/Medication 
 
Skip Logic: If Step Two (e.g. Psychoeducat... Is Selected, Then Skip To If you were 
starting treatment, what ...If Step Three (e.g. Psychother... Is Selected, Then Skip To If 
you were starting treatment, what ...If Step Four (e.g. Intensive O... Is Selected, Then Skip 
To If you were starting treatment, what ...  
 
26. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong 
 
27. If you were starting treatment, what treatment within step four of the Stepped-
Care model would you prefer? 
o Intensive Outpatient/Partial Day Program 
o Inpatient Program 
 
28. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong  
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Below are some alternative types of care that might also be effective for individuals 
experiencing depression. For the following question, please indicate the number that best 
corresponds to your views.  
 
Alternative forms of treatment might include any of the following: Physical Activity 
Programs (i.e. exercise/nutrition based classes to promote wellness), Yoga, Meditation, 
and Group-Based Support Programs (i.e. groups that are not led by a mental health 
professional). 
  
29. Do you find ANY of the alternatives forms of treatment to be acceptable for 
treating depressive symptoms? 
Not Acceptable 2 Moderately Acceptable 4 Very Acceptable  
 
Skip Logic: If Not Acceptable Is Selected, Then Skip To End of Survey  
 
30. Among the alternative forms of treatment, which would you MOST prefer to 
engage in? 
o Physical Activity Programs 
o Yoga 
o Meditation 
o Group-Based Peer Support Programs 
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31. How strong is this preference? 
Not Strong 2 Moderately Strong 4 Very Strong  
 
 
 
 
 
Thank you for participating in this survey! 
 
